Serum protein leakage in Alzheimer's disease revisited

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 173-189

  Munoz, David G ^a,c   Erkinjuntti, Timo ^a,b   Gaytan Garcia, Sylvia ^b   Hachinski, Vladimir ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF HELSINKI   (Finland)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMYLOID P COMPONENT; IMMUNOGLOBULIN G; PLASMA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CELL LABELING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; MULTIINFARCT DEMENTIA; NERVE CELL; NERVE DEGENERATION; SENILE PLAQUE; WHITE MATTER;

EID: 0030725595     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48469.x     Document Type: Conference Paper

References (40)

1. GLENNER, G. G. 1979. Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). Med. Hypotheses 5: 1231-1236.
2. HARDY, J. A., D. M. MANN, P. WESTER & B. WINBLAD. 1986. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol. Aging 7: 489-502.
3. WONG, C. W., V. QUARANTA & G. G. GLENNER. 1985. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc. Natl. Acad. Sci. USA 82: 8729-8732.
4. HACHINSKI, V. C. & D. G. MUNOZ. 1991. Leuko-araiosis. An update. Bull. Clin. Neurosci. 56: 24-33.
5. MUNOZ, D. G., S. M. HASTAK, B. HARPER, D. LEE & V. C. HACHINSKI. 1993. Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging. Arch. Neurol. 50: 492-497.
6. MUNOZ, D. G. 1991. The pathological basis of multi-infarct dementia. Alzheimer Dis. Assoc. Disord. 5: 77-90.
7. ELOVAARA, I., A. ICEN, J. PALO & T. ERKINJUNTTI. 1985. CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis. J. Neurol. Sci. 70: 73-80.
8. ALAFUZOFF, I., R. ADOLFSSON, G. BUCHT & B. WINBLAD. 1983.Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia. J. Neurol. Sci. 60: 465-472.
9. JONKER, C., P. EIKELENBOOM & P. TAVENIER. 1982. Immunological indices in the cerebrospinal fluid of patients with presenile dementia of the Alzheimer type. Br. J. Psychiatry 140: 44-49.
10. LEONARDI, A., C. GANDOLFO, C. CAPONNETTO, L. ARATA & R. VECCHIA. 1985. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. J. Neurol. Sci. 67: 253-261.
11. KAY, A. D., C. MAY, N. M. PAPADOPOULOS, R. COSTELLO, J. R. ATACK, J. S. LUXENBERG, N. R. CUTLER & S. I. RAPOPORT. 1987. CSF and serum concentrations of albumin and IgG in Alzheimer's disease. Neurobiol. Aging 8: 21-25.
12. FROLICH, L., J. KORNHUBER, R. IHL, J. FRITZE, K. MAURER & P. RIEDERER. 1991. Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. Eur. Arch. Psychiatry Clin. Neurosci. 240: 363-366.
13. BLENNOW, K., A. WALLIN, P. FREDMAN, I. KARLSSON, C. G. GOTTFRIES & L. SVENNERHOLM. 1990. Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol. Scand. 81: 323-326.
14. SCHLAGETER, N. L., R. E. CARSON & S. I. RAPOPORT. 1987. Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography. J. Cereb. Blood Flow Metab. 7: 1-8.
15. FRIEDLAND, R. P. 1989. Positron imaging in dementing illnesses. J. Neuropsychiatry. Clin. Neurosci. 1: S56-S60.
16. KLATZO, I., E. CHUI, K. FUJIWARA & M. SPATZ. 1980. Resolution of vasogenic brain edema. Adv. Neurol. 28: 359-373.
17. COLE, D. J., J. S. MATSUMURA, J. C. DRUMMOND, R. L. SCHULTZ & M. H. WONG. 1991. Time- and pressure-dependent changes in blood-brain barrier permeability after temporary middle cerebral artery occlusion in rats. Acta Neuropathol. (Berl.) 82: 266-273.
18. WESTERGAARD, E., G. GO, I. KLATZO & M. SPATZ. 1976. Increased permeability of cerebral vessels to horseradish peroxidase induced by ischemia in Mongolian gerbils. Acta Neuropathol. (Berl.) 35: 307-325.
19. WISNIEWSKI, H. M., A. S. LOSSINSKY, R. C. MORETZ, A. W. VORBRODT, H. LASSMANN & R. I. CARP. 1983. Increased blood-brain barrier permeability in scrapie-infected mice. J. Neuropathol. Exp. Neurol. 42: 615-626.
20. B. COUTINHO, L. M., A. HARTMANN, K. A. HOSSMANN & T. ROMMEL. 1985. Effect of dexamethasone on serum protein extravasation in experimental brain infarcts of monkey: An immunohistochemical study. Acta Neuropathol. (Berl.) 65: 255-260.
21. NAG, S. 1984. Cerebral changes in chronic hypertension: Combined permeability and immunohistochemical studies. Acta Neuropathol. (Berl.) 62: 178-184.
22. LOBERG, E. M. & A. TORVIK. 1991. Uptake of plasma proteins into damaged neurons. An experimental study on cryogenic lesions in rats. Acta Neuropathol. (Berl.) 81: 479-485.
23. SOKRAB, T. E., H. KALIMO & B. B. JOHANSSON. 1990. Parenchymal changes related to plasma protein extravasation in experimental seizures. Epilepsia 31: 1-8.
24. WISNIEWSKI, H. M. & P. B. KOZLOWSKI. 1982. Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Ann. N. Y. Acad. Sci. 396: 119-129.
25. ALAFUZOFF, I., R. ADOLFSSON, I. GRUNDKE IQBAL & B. WINBLAD. 1987. Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study. Acta Neuropathol. (Berl.) 73: 160-166.
26. ALAFUZOFF, I., R. ADOLFSSON, I. GRUNDKE-IQBAL & B. WINBLAD. 1985. Perivascular deposits of serum proteins in cerebral cortex in vascular dementia. Acta Neuropathol. (Berl.) 66: 292-298.
27. ROZEMULLER, J. M., P. EIKELENBOOM, W. KAMPHORST & F. C. STAM. 1988. Lack Of evidence for dysfunction of the blood-brain barrier in Alzheimer's disease: an immunohistochemical study. Neurobiol. Aging 9: 383-391.
28. KALARIA, R. N. & I. GRAHOVAC. 1990. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res. 516: 349-353.
29. CORIA, F., E. CASTANO, F. PRELLI, M. LARRONDO-LILLO, S. VAN-DUINEN, M. L. SHELANSKI & B. FRANGIONE. 1988. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab. Invest. 58: 454-458.
30. DUONG, T., E. C. POMMIER & A. B. SCHEIBEL. 1989. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol. (Berl.) 78: 429-437.
31. PERLMUTTER, L. S., D. SAPERIA, E. BARRON, H. C. CHUI & M. MYERS. 1995. Localization of amyloid P component in human brain: Vascular staining patterns and associations with Alzheimer's disease lesions. J. Comp. Neurol. 352: 92-105.
32. ERKINJUNTTI, T., M. HALTIA, J. PALO, R. SULKAVA & A. PAETAU. 1988. Accuracy of the clinical diagnosis of vascular dementia: A prospective clinical and post-mortem neuropathological study. J. Neurol. Neurosurg. Psychiatry 51: 1037-1044.
33. AMERICAN PSYCHIATRIC ASSOCIATION COMMITTEE ON NOMENCLATURE AND STATISTICS. 1987. Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). 3, revised. American Psychiatric Association. Washington, D.C.
34. ROMAN, G. C., T. K. TATEMICHI, T. ERKINJUNTTI, J. L. CUMMINGS, J. C. MASDEU, J. H. GARCIA, L. AMADUCCI, J. M. ORGOGOZO, A. BRUN, A. HOFMAN, et al. 1993. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS- AIREN International Workshop. Neurology 43: 250-260.
35. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN, R. KATZMAN, D. PRICE & E. M. STADLAN. 1984. Clinical diagnosis of Alzheimer's disease. Neurology 34: 939-944.
36. TOMLINSON, B. E., G. BLESSED & M. ROTH. 1970. Observations on the brains of demented old people. J. Neurol. Sci. 11: 205-242.
37. MIRRA, S. S., A. HEYMAN, D. MCKEEL, S. M. SUMI, B. J. CRAIN, L. M. BROWNLEE, F. S. VOGEL, J. P. HUGHES, G. VAN-BELLE & L. BERG. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
38. KHACHATURIAN, Z. S. 1985. Diagnosis of Alzheimer's Disease. Arch. Neurol. 42: 1097-1105.
39. LOBERG, E. M., B. HASSEL, F. FONNUM & A. TORVIK. 1994. Early entry of plasma proteins into damaged neurons in brain infarcts. An immunohistochemical study on experimental animals. APMIS 102: 771-776.
40. DALMAU, J., H. M. FURNEAUX, M. K. ROSENBLUM, F. GRAUS & J. B. POSNER. 1991. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 41: 1757-1764.